NERVGEN PHARMA CORP.

NervGen Pharma Corp. is a pharmaceutical company based in Canada that engages in scientific research and experimental development. The company focuses its operational efforts on preclinical development, clinical and regulatory activities, chemistry manufacturing and controls, and the licensing and protection of patents. Operating as a development-stage enterprise within the pharmaceutical preparations industry, the business does not report distinct commercial operating segments or commercial product sales to external customers. Its core activities center on proprietary research, development initiatives, and related advisory work directed by executive leadership and medical advisors.

The company maintains its corporate headquarters and principal executive offices in Vancouver, British Columbia, Canada. Its administrative and corporate operations encompass organizational relationships, regulatory reporting, and legal processes spanning Canada, the United States, and Australia. The company manages executive functions, board committees, and compliance procedures from its Canadian base. No retail stores, manufacturing facilities, or physical branch networks are reported in the filing.

Summary of the business section of Nervgen Pharma's latest annual report, written by StockData.